Fundraising Fox

FemTherapeutics

5 known investors

FemTherapeutics develops treatment solutions for pelvic organ prolapse (POP), a condition affecting women who have had a vaginal delivery. The company aims to improve on existing options such as poorly fitting pessaries and invasive surgery.

FemTechHealthtechMedical Devices

Investors · 5

2048 VenturesNew York · $500K – $3M
SheBootOttawa · $300K
The 51 VenturesCalgary
Investissement Quebecreported · 2 sourcesQuebec City

Also in the syndicate · 1

The51 Ventures

Funding

SEC filings, press & company announcements

$1.9M disclosed across 1 of 2 rounds · 2023

Source: company announcements and press reports — follow each round's link for the claim.

In the news

11 women's health startups to watch - Global Venturingglobalventuring.com · Aug 2024Medtech startup FemTherapeutics gathers $1.85m in VC fundingventurecapitaljournal.com · Jun 2023FemTherapeutics raises $2.5 million CAD to address pelvic floor disorders with custom vaginal prostheticsbetakit.com · Jun 2023Femtech Startup Raises $1.8 Million – But Women’s Health Is Still Severely Underfundedthestoryexchange.org · May 2023FemTherapeutics Raises $1.8 Million To Advance Women’s Health With Its Patient-Specific Gynecological Prostheticsforbes.com · May 2023

Frequently asked questions

What does FemTherapeutics do?
FemTherapeutics develops treatment solutions for pelvic organ prolapse (POP), a condition affecting women who have had a vaginal delivery. The company aims to improve on existing options such as poorly fitting pessaries and invasive surgery.
Who are FemTherapeutics's investors?
FemTherapeutics's investors include 2048 Ventures, SheBoot, The 51 Ventures, Investissement Quebec.
How much funding has FemTherapeutics raised?
FemTherapeutics has disclosed $1.9M raised across 1 of its 2 known rounds.